Posted on February 24th, 2010 by Beth Backus
Genetic Engineering & Biotechnology News
JACKSONVILLE, Fla. Researchers at the Mayo Clinic campus in Florida have found that PKC-iota (PKC), an oncogene important in colon and lung cancers, is over-produced in pancreatic cancer and is linked to poor patient survival. They also found that genetically inhibiting PKC in laboratory animals led to a significant decrease in pancreatic tumor growth and spread.
Tags: Mayo Clinic Jacksonville
You must be logged-in to the site to post a comment.